EP Patent

EP2281503B1 — Method for performing intra-operative angiography

Assigned to National Research Council of Canada · Expires 2015-04-29 · 11y expired

What this patent protects

The device is provided with a laser (1) for exciting the fluorescent imaging agent which emits radiation at a wavelength that causes any of the agent located within the vasculature or tissue of interest (3) irradiated thereby to emit radiation of a particular wavelength. Advantag…

USPTO Abstract

The device is provided with a laser (1) for exciting the fluorescent imaging agent which emits radiation at a wavelength that causes any of the agent located within the vasculature or tissue of interest (3) irradiated thereby to emit radiation of a particular wavelength. Advantageously, a camera capable of obtaining multiple images over a period of time, such as a CCD camera (2) may be used to capture the emissions from the imaging agent. A band-pass filter (6) prevents the capture of radiation other than that emitted by the imaging agent. A distance sensor (9) incorporates a visual display (9a) providing feedback to the physician saying that the laser be located at a distance from the vessel of interest that is optimal for the capture of high quality images.

Drugs covered by this patent

Patent Metadata

Patent number
EP2281503B1
Jurisdiction
EP
Classification
Expires
2015-04-29
Drug substance claim
No
Drug product claim
No
Assignee
National Research Council of Canada
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.